Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry

Part of paid clinical trials in Gilbert, Arizona.

Sponsor
Galvanize Therapeutics, Inc.
Study ID
NCT05851430
Status
Recruiting
Apply to this trial

Conditions

  • Soft Tissue Lesion

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • PEF ablation — DEVICE
    Pulsed Electric Field (PEF) Ablation per institutional standard of care

Study Details

The goal of this observational registry is to assess the use and performance of Galvanize PEF technology in a real-world setting. The main questions it aims to answer are: * PEF utilization and performance * Monitor safety outcomes and inform future generation devices. Participants will undergo the PEF procedure and be followed per institutional standard of care.

Key Dates

Start date
Jun 23, 2025
Status verified
Apr 2026
Primary completion
Jun 30, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Aliya PEF ablation
    Patients will undergo PEF ablation per institutional standard of care

Primary Outcome Measure

Anesthesia Type Usage for PEF Procedure [ Time Frame: PEF procedure ]

Central Contacts

Locations (10)

FacilityCityStateZIPSite coordinators
Banner HealthGilbertArizona85234
Robert Flynn
[email protected]
Archan Shaw, MD (PRINCIPAL_INVESTIGATOR)
Eisenhower Medical CenterRancho MirageCalifornia92270
Justin Thomas, MD (PRINCIPAL_INVESTIGATOR)
NCH BakerNaplesFlorida34102
Yanna Prishchepa, RN
[email protected]
David Lindner, MD (PRINCIPAL_INVESTIGATOR)
New York Presbyterian Langone HealthNew YorkNew York10016
Priya Bhattacharji
[email protected]
William Moore, MD (PRINCIPAL_INVESTIGATOR)
Daniel Sterman, MD (SUB_INVESTIGATOR)
Jamie Bessich, MD (SUB_INVESTIGATOR)
Duke University HospitalDurhamNorth Carolina27705
Jessica Shier
[email protected]
Kamran Mahmood, MD (PRINCIPAL_INVESTIGATOR)
Joseph Mammarappallil (SUB_INVESTIGATOR)
Coral Giovaccini, MD (SUB_INVESTIGATOR)
Michael Harowicz, MD (SUB_INVESTIGATOR)
Lankenau Institute for Medical Research (LIMR)WynnewoodPennsylvania19096
Jessica Burrell, BA, BS, CCRP
[email protected]
Patrick Ross, MD, PhD (PRINCIPAL_INVESTIGATOR)
Thomas Meyer, MD (SUB_INVESTIGATOR)
Ricky Tong, MD, PhD (SUB_INVESTIGATOR)
AnMed HealthAndersonSouth Carolina29621
Andrea Franks
[email protected]
Abhijit Raval, MD (PRINCIPAL_INVESTIGATOR)
UT Southwestern Medical CenterDallasTexas75390
Rhoda Annoh Gordon
[email protected]
Muhanned Abu-Hijleh, MD (PRINCIPAL_INVESTIGATOR)
Inderpal Sarkaria, MD (SUB_INVESTIGATOR)
Takashi Eguchi, MD (SUB_INVESTIGATOR)
Audra Schwalk, MD (SUB_INVESTIGATOR)
Aitua Salami, MD (SUB_INVESTIGATOR)
University of Texas-TylerTylerTexas75708
George Gass, MD (PRINCIPAL_INVESTIGATOR)
Debbie Fielder, MD (SUB_INVESTIGATOR)
Christopher Herrick, MD (SUB_INVESTIGATOR)
West Virginia UniversityMorgantownWest Virginia26506
Saiesh Vopparu, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Gilbert, AZ

By research site
Banner Health· Gilbert, AZEisenhower Medical Center· Rancho Mirage, CANCH Baker· Naples, FLNew York Presbyterian Langone Health· New York, NYDuke University Hospital· Durham, NCLankenau Institute for Medical Research (LIMR)· Wynnewood, PA

Related Studies